Skin Cancer

>

Latest News

FDA on clipboard
Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma

November 24th 2024

The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated melanoma.

doctor in white coat holding hand out with the word "immunotherapy" floating above
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers

November 12th 2024

melanoma/skin
10-Year Data Support Pembrolizumab as Standard for Advanced Melanoma

September 21st 2024

Two Phase 3 Trials of Pembrolizumab in NSCLC, CSCC to Be Discontinued By Merck
Two Phase 3 Trials of Pembrolizumab in NSCLC, CSCC to Be Discontinued By Merck

September 8th 2024

Close up illustration of skin.
Oncolytic Peptide VP-315 Reduces Tumor Size in Patients With Basal Cell Carcinoma

August 31st 2024

Latest CME Events & Activities

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

December 6, 2024

Register Now!

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.